Proteolytically Stable Cyclic Decapeptide for Breast Cancer Cell Targeting-Reference-Cited by-同舟云学术

Proteolytically Stable Cyclic Decapeptide for Breast Cancer Cell Targeting

Published:2017-06-06 Issue:12 Volume:60 Page:4893-4903
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Raghuwanshi Yogita¹,Etayash Hashem¹^ORCID,Soudy Rania¹,Paiva Igor¹,Lavasanifar Afsaneh¹^ORCID,Kaur Kamaljit¹²^ORCID

Affiliation:

1. Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, Alberta T6G 2E1, Canada

2. Chapman University School of Pharmacy (CUSP), Harry and Diane Rinker Health Science Campus, Chapman University, Irvine, California 92618-1908, United States

Funder

Natural Sciences and Engineering Research Council of Canada

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.7b00163

Reference30 articles.

1. Antibody targeted drugs as cancer therapeutics

2. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status

3. Oligonucleotide Aptamers: New Tools for Targeted Cancer Therapy

4. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index

5. Use of Targeted Liposome-based Chemotherapeutics to Treat Breast Cancer

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular farming for sustainable production of clinical‐grade antimicrobial peptides;Plant Biotechnology Journal;2024-04-29

2. Peptide-Based Therapeutics in Cancer Therapy;Molecular Biotechnology;2023-09-28

3. Peptide–Drug Conjugate Targeting Keratin 1 Inhibits Triple-Negative Breast Cancer in Mice;Molecular Pharmaceutics;2023-06-12

4. Current therapeutic approaches and promising perspectives of using bioengineered peptides in fighting chemoresistance in triple-negative breast cancer;Biochemical Pharmacology;2023-04

5. A Small Peptide Increases Drug Delivery in Human Melanoma Cells;Pharmaceutics;2022-05-11